<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04392492</url>
  </required_header>
  <id_info>
    <org_study_id>MANTA TAVI</org_study_id>
    <nct_id>NCT04392492</nct_id>
  </id_info>
  <brief_title>Vascular Closure Device in Transcatheter Aortic Valve Replacement</brief_title>
  <official_title>Plug-based Percutaneous Vascular Closure Device in Transcatheter Aortic Valve Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Evaluation of the safety and efficacy of a percutaneous plug-based large-bore vascular&#xD;
      closure device for femoral artery closure in an unselected consecutive patient cohort&#xD;
      undergoing transcatheter aortic valve implantation in a single-center prospective study.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 25, 2017</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>6 Weeks</target_duration>
  <primary_outcome>
    <measure>Number of patients with major vascular complications</measure>
    <time_frame>6 week follow up</time_frame>
    <description>Major vascular access site complications according to the VARC-2 definitions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with minor vascular complications</measure>
    <time_frame>6 week follow up</time_frame>
    <description>Minor vascular access site complications according to the VARC-2 definitions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with vascular closure device failure</measure>
    <time_frame>6 week follow up</time_frame>
    <description>Percutaneous vascular closure device failure according to the VARC-2 definitions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with life-threatening, disabling or major bleeding</measure>
    <time_frame>6 week follow up</time_frame>
    <description>Life-threatening, disabling or major bleeding complications according to the BARC definitions</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Aortic Valve Stenosis</condition>
  <arm_group>
    <arm_group_label>Patients undergoing transfemoral TAVI with MANTA closure</arm_group_label>
    <description>Patients undergoing transfemoral transcatheter aortic valve replacement with femoral access site closure using the novel plug-based vascular closure device (MANTA, Teleflex/Essential Medical Inc., Malvern, Pennsylvania, USA).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MANTA vascular closure device</intervention_name>
    <description>Femoral access site closure using the MANTA closure device</description>
    <arm_group_label>Patients undergoing transfemoral TAVI with MANTA closure</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients undergoing TAVI at the Karolinska University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing transfemoral TAVI at the Karolinska University Hospital&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing TAVI with access other than transfemoral&#xD;
&#xD;
          -  Use of closure device other than MANTA&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Cardiology, Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>May 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2020</study_first_posted>
  <last_update_submitted>November 30, 2020</last_update_submitted>
  <last_update_submitted_qc>November 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska University Hospital</investigator_affiliation>
    <investigator_full_name>Magnus Dal√©n</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

